Related Experiment Video
Updated: May 28, 2025

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
[Hypokalemia: Not Just Tubulopathies]
Andrea Mancini1, Ilaria Losciale2, Claudio Petrillo3
1UOC di Nefrologia e Dialisi Ospedale di Venere, Bari.
Insights
Severe hypokalemia can cause paralysis and be life-threatening. Genetic testing identified hypokalemic periodic paralysis type I in a young man with severe hypokalemia and paralysis.
Area of Science:
- Nephrology
- Genetics
- Internal Medicine
Background:
- Hypokalemia (low potassium) is a common electrolyte disorder with potential cardiovascular complications.
- Kidney function is crucial for potassium homeostasis, involving nephrologists in its management.
- Severe hypokalemia can lead to serious morbidity and mortality.
Observation:
- A 24-year-old male presented with emesis and hyperpyrexia, rapidly developing severe hypokalemia.
- The patient experienced ascending flaccid paralysis despite prompt potassium chloride treatment.
- Intensive therapy was required to manage complications arising from the severe hypokalemia.
Findings:
- A multidisciplinary approach and genetic testing were crucial for diagnosis.
- A heterozygous mutation in the CACNA1S gene confirmed hypokalemic periodic paralysis type I.
- This case highlights diagnostic and therapeutic challenges in managing severe hypokalemia.
Implications:
- Early recognition and management of hypokalemia are vital to prevent fatal outcomes.
- Genetic testing plays a key role in diagnosing specific types of periodic paralysis.
- Understanding the link between hypokalemia and genetic mutations improves patient care and outcomes.
Abstract:
Hypokalemia is among the most common electrolyte abnormalities, often well tolerated, but sometimes responsible for an increase in morbidity and mortality due to cardiovascular causes. The kidneys play a key role in potassium homeostasis, making the nephrologist the professional directly involved in the diagnosis and treatment of this condition. We present the clinical case of a 24-year-old man who came in with multiple episodes of emesis and hyperpyrexia. The patient rapidly developed severe hypokalemia with ascending flaccid paralysis. Despite early treatment with potassium chloride, intensive therapy was necessary to manage the complications. The clinical case illustrates the diagnostic and therapeutic challenges encountered and demonstrates how a multidisciplinary approach and a thorough diagnostic process, including genetic testing, identified a heterozygous mutation in the CACNA1S gene, confirming the diagnosis of hypokalemic periodic paralysis type I. The importance of early recognition and appropriate management of hypokalemia is emphasized to prevent potentially fatal complications.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Heart Failure Drugs: Diuretics
Roles of Electrolytes: Sodium and Potassium
Heart Failure Drugs: Inotropic Agents
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...

